September 27, 2010

Pfizer has halted a late-stage trial of a drug therapy in men with prostate cancer,...

September 27, 2010

The Hart-Scott-Rodino waiting period for Bristol-Myers Squibb’s acquisition of Seattle-based biotech company ZymoGenetics has expired,...

September 26, 2010

An investigational drug made by Johnson & Johnson for treating pain showed significant reduction in...

September 22, 2010

The Food and Drug Administration has accepted AstraZeneca’s regulatory application for an investigational cancer drug,...

September 21, 2010

Swiss drug maker Novartis said its investigational drug is the first to show promise in...

September 20, 2010

A Food and Drug Administration advisory committee has recommended approval of a drug for patients...

September 19, 2010

Biotech company Genentech has amended its application to the Food and Drug Administration seeking an...

September 16, 2010

Boehringer Ingelheim has started a late-stage clinical trial of a drug for treating breast cancer,...

September 16, 2010

Emergent BioSolutions has landed a $51 million contract from the Department of Health and Human...

September 16, 2010

The Food and Drug Administration has accepted for review a regulatory approval application for a...

September 16, 2010

An advisory committee of the Food and Drug Administration has given a thumbs-down to a...

September 13, 2010

Biotech companies Seattle Genetics and Genmab will collaborate to develop antibody treatments for cancer, the...

September 12, 2010

The Food and Drug Administration has accepted a regulatory approval application for a flu vaccine...

September 12, 2010

The Food and Drug Administration did not completely withdraw from the market a drug used...

September 12, 2010

An investigational treatment for HIV by Gilead Sciences that combines four drugs in one tablet...

September 9, 2010

Close to 400 drugs and vaccines are in development for fighting infectious diseases, according to...

September 9, 2010

Diplomat Specialty Pharmacy isn’t the only one to earn a spot on Inc. magazine’s list...

September 8, 2010

Inc. magazine has ranked Diplomat Specialty Pharmacy as one of the fastest-growing private companies in...

September 8, 2010

NEW YORK British drug maker GlaxoSmithKline and biotech company Genmab have started a late-stage trial...

September 8, 2010

British drug maker Shire is working with Cambridge, Mass.-based Acceleron Pharma to develop treatments for...

September 6, 2010

Biotech drugs for treating Alzheimer’s disease will more than triple the size of the market...

September 2, 2010

Pfizer is pulling out of a development deal for a potential brain cancer drug, saying...

August 31, 2010

A specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes...

August 31, 2010

The Food and Drug Administration has granted priority review for a diabetic macular edema treatment....